fbpx

Blog

National President’s Message:
 COVID-19 Update

13 March 2020

 

You will be aware of the significant escalation this week in the public health response to COVID-19 in the Australian community. This is consistent with global public health responses, particularly following the World Health Organization’s characterising COVID-19 as a pandemic. I am committed to keeping you informed of the latest updates so that pharmacists can play their part in protecting themselves, their colleagues and the Australian community. The next couple of weeks will be pivotal in trying to contain transmission of COVID-19 in Australia so that our health system can deal with the likely impact of this virus on Australian shores.

 

We have created a dedicated COVID-19 webpage to keep pharmacists updated on the latest information and advice as it becomes available. It contains links to up-to-date information, guidance and resources from governments and other trusted sources for pharmacists and your patients.

 

We continue to monitor the COVID-19 pandemic and have dedicated staff working to ensure that members are represented and supported as you support the health of Australians on the frontline.

 

This week the Australian Government made two significant announcements affecting pharmacists:

 

COVID-19 health package

 

There were two measures in this package relevant to pharmacists. The first of these was the introduction of $25 million to a Home Medicines Service which will enable patients to have their PBS/RPBS prescriptions filled online or remotely, and have their medicines delivered to their home.

 

The second measure was $5 million to fast-track the introduction of electronic prescriptions through engagement with software vendors. This is expected to bring electronic prescription capability online within two months.

 

Other measures in this $2.4 billion package included expanded MBS funding for telehealth consultations which is expected to accelerate demand for electronic prescribing.

 

This week I met with senior Department of Health officials to discuss how the Home Medicine Service and electronic prescriptions will be implemented. PSA is working with the government to inform these measures and will provide members with further details as soon as they are available.

 

COVID-19 economic stimulus package

 

Business measures announced, including grants of up to $25,000 with a minimum payment of $2,000 for small and medium businesses that employ staff with an annual turnover of up to $50 million to support community pharmacies during the pandemic.

 

I know that many of you are concerned about the medicines supply chain, and on the background of current problems with medicines shortages, whether COVID-19 will exacerbate the situation. We are working closely with TGA’s Medicine Shortages Working Party to ensure that the medicines supply chain remains robust and that patients can access the medicines they need, when they need them. I have written to the Presidents of both the AMA and the RACGP to communicate to their members that the writing of section 49 prescriptions (known as regulation 24 prescriptions) has the potential to disrupt the supply chain and could mean that some patients have a disproportionate supply of medicines.

 

We are also working closely with the Pharmacy Guild of Australia to ensure that continued dispensing arrangements can apply across Australia for medicines for chronic conditions, and that there is an opportunity to provide alternate supplies of medicines should medicines shortages be exacerbated by COVID-19.

 

PSA will continue to monitor this dynamic situation and I will write to you each Friday to keep you informed. Additionally PSA will use our communication channels – including our dedicated COVID-19 website and social media – to provide you with the most current and up-to-date information.

 

If you have questions or require support in your role supporting the community, please contact us via 1300 369 772 or policy@psa.org.au.

 

Yours sincerely,

Associate Professor Chris Freeman

National President

Victorians to be better protected by removing barriers to vaccination by pharmacists

12 March 2020

 

Pharmacists will now be able to protect more Victorians against vaccine-preventable diseases in a move announced by the Victorian Government today that has been welcomed by the Pharmaceutical Society of Australia (PSA).

 

For the first time, trained pharmacists in Victoria will be able to administer Meningococcal ACWY to people aged 15 years and over. The minimum age for pharmacist-administered measles-mumps-rubella and whooping cough vaccines has been lowered to people aged 15 years (previously 16 years)

 

In addition, as previously announced by Victoria Health Minister Jenny Mikakos last year, trained pharmacists will also be able to administer influenza vaccinations to people aged 10 years and above (previously 16 years and over). All changes will come into effect on 1 April 2020.

 

Changes to the Secretary Approval: Pharmacist Immunisers gazetted today will also allow greater flexibility for pharmacists to provide vaccinations via mobile and outreach services of a hospital, pharmacy or pharmacy depot.

 

PSA Victorian President John Jackson welcomed the move to increase access to pharmacist-administered vaccinations services in Victoria, and in particular to formally lower the minimum vaccination age from 16 years to 10 years for influenza vaccinations in readiness for the 2020 influenza season.

 

“At a time when our health care system is under extreme pressure, increasing options for Victorians to access vaccination services is extremely helpful,” Mr Jackson said.

 

“Our members have experienced parent’s frustrations in recent influenza seasons where it was difficult to arrange access for their children to get their seasonal influenza vaccine and these changes will go a long way to addressing this hurdle.”

 

Mr Jackson commended the government’s decision to allow pharmacists to protect more Victorians from influenza and other vaccine-preventable diseases.

 

“Pharmacists are well trained in the administration of these vaccines and are more accessible to the community than any other health provider. Pharmacists have become an integral part of Victoria’s vaccination provider network, and these changes will allow pharmacists to make a greater contribution to increasing immunity in our community,” he said.

 

PSA commends the Victorian Government and the Department of Health and Human Services for continuing to support the use of pharmacists’ expertise and training.

 

“As the peak national body for pharmacists, PSA has advocated for many years, including most recently in PSA’s Victorian pre-budget submission, to allow pharmacists to deliver more vaccinations to a wider age range of patients. We will continue to work closely with the Victorian Government to remove more barriers which restrict pharmacists from administering other vaccines to protect the Victorian community.”

 

Media contact: Stefanie Johnston 0417 910 738

 

Download media release

Federal Government’s $17.6 billion stimulus package will assist Australians and support pharmacists during COVID-19

Thursday, 12 March 2020

 

The Pharmaceutical Society of Australia (PSA) has welcomed the Federal Government’s $17.6 billion stimulus package which will support vulnerable Australians and the health professionals who support them during the COVID-19 outbreak.

 

The announcement includes grants of up to $25,000 with a minimum payment of $2000 for small and medium businesses that employ staff with an annual turnover of up to $50 million and will be provided through the tax system, tax free.

 

PSA National President Associate Professor Chris Freeman said this announcement on the back of yesterday’s health package would assist in supporting community pharmacies and the pharmacists they employ during COVID-19.

 

“A significant number of pharmacies around Australia will be eligible for the grant at the maximum level which will allow them to continue to support their workforce and continue to provide an invaluable service to the community,” he said.

 

“As frontline health professionals, pharmacists will continue to play a key role during COVID-19 and the influenza season and these measures announced today will provide important stimulus to many pharmacies to continue to provide much needed healthcare to their patients.

 

As part of the announcement, the Government has also increased the instant asset write-off threshold from $30,000 to $150,000 and expanded access to include businesses with aggregated annual turnover of less than $500 million (up from $50million) until 30 June 2020.

 

Businesses with a turnover of less than $500 million will be able to deduct an additional 50 per cent of the asset cost in the year of purchase (through to 30 June 2021).

 

PSA also welcomes the pragmatic measure of abolishing waiting-periods for social security sickness payments for casual workers, who may miss shifts because they contract coronavirus or are asked to self-isolate,

 

“This measure will not only financially support those who are sick or in isolation, but also reduce the likelihood of people who are unwell attending work,” A/Prof Freeman said. “This is particularly important in the health sector, where many frontline health professionals and support staff are employed on a casual basis”.

 

PSA will continue to work with the Government and provide details to the profession of these initiatives.

 

“Support for the profession, including the announcement yesterday of funding for home medicine services and electronic prescriptions together with today’s business and social security measures are essential to ensure pharmacists can continue their crucial role protecting Australians.”

 

Media contact: PSA Media: 0487 922 176

 

Download media release

National President’s Message:
 COVID-19 Update

11 March 2020

 

As the COVID-19 situation unfolds, I would like to commend you and your fellow pharmacists for the mature way our profession has been tackling this health crisis. The Minister for Health, Greg Hunt, has asked that we pass on his thanks and has stated “I would like to thank all pharmacists as frontline health professionals and the role you are playing in assisting patients in the early phases of COVID-19 pandemic response”.

 

A number of PSA members have raised with me their struggles in accessing the right information about COVID-19. PSA has collated the latest available resources on our website and this is available here. This information will be updated on a regular basis, and I intend to write to you as members on a weekly basis with a summary of the developments on COVID-19.

 

I know that members are concerned about COVID-19 and at this stage the best way to access the most up to date information about COVID-19, including symptoms is through the Department of Health COVID-19 webpage. The Department of Health has also developed a comprehensive list of resources, including information in assessing people who have recently travelled internationally. These resources have been translated into a number of languages. This information is available here.

 

Access to Personal Protective Equipment (PPE) is of the utmost priority and will only become more important over the coming weeks. I urge you all to contact your Primary Health Networks to request an adequate supply of PPE, to protect yourself, your colleagues and your patients. If you are having difficulties accessing PPE from any PHNs, please let me or your state branch office of PSA know of the difficulties, and we will follow this up on your behalf. There are restrictions regarding the use of these PPE and information about their intended use is available here.

 

Last week, I attended the primary care and aged care preparedness forums which discussed the COVID-19 outbreak and the next steps in Australia’s response. There are likely to be significant changes in how patients can access healthcare in the coming weeks and months and we will keep you informed of these changes. The challenges facing rural and remote Australia, Aboriginal and Torres Strait communities, and our aged care sector is of high priority. PSA highlighted the issues of availability of PPE stock, stockpiling of medicines, and the need for continuation of emergency dispensing of chronic disease medicines.

 

Announced today as part of the Government’s response to COVID-19 is a $2.4 billion health package including the establishment of telehealth items for GPs and the establishment of fever clinics in states and territories. The Commonwealth has also announced two specific measures related to pharmacists. The implementation of electronic prescriptions will be expedited over the short-term and a payment to community pharmacy for medicine home delivery will be applied for patients impacted by COVID-19. We will keep you informed as more details of these measures are worked through with the Department of Health.

 

I know many of you have raised concerns about requests from patients for multiple repeats of medicines, and regulation 49 prescriptions (previously regulation 24) which could result in inappropriate medicines stockpiling and possibly medicine shortages, if this behaviour continues. PSA has today participated in a Medicine Shortages Working Party meeting with the TGA and other key stakeholders in the medicine supply chain. We have heard the concerns of members and PSA wants to reassure pharmacists that we are actively working with National Pharmaceutical Services Association and the Pharmacy Guild of Australia to keep members up-to-date on the current supply situation. Pharmacists are encouraged to reassure patients that there is no need to panic and everything is being done to ensure medicines are available.

 

I encourage you to bookmark our dedicated webpage to keep you updated on the latest information and advice on COVID-19. This webpage can be accessed here and will be updated frequently. PSA will also keep members informed on our PSA and Early Career Pharmacist Facebook pages.

 

I encourage you to highlight any issues on the ground with the COVID-19 pandemic planning, and members should feel free to communicate with PSA at policy@psa.org.au.

 

Yours sincerely,

Associate Professor Chris Freeman

National President

Home medicines services and electronic prescriptions to support Australians during COVID-19

Wednesday, 11 March 2020

 

Pharmacists will be able to better support vulnerable patients following the Federal Government’s announcement to fund home medicines services as part of its $2.4 billion COVID-19 health package.

 

PSA National President Associate Professor Chris Freeman welcomed the Government’s announcement that $25 million will be allocated to fund home medicines services which will enable patients to have their PBS prescriptions filled online or remotely, and have their medicines delivered to their home.

 

These measures will support the announced telehealth Medicare items for GPs to help contain the spread of the virus and allow GPs to conduct consultations via phone or video.

 

“However, the effectiveness of this initiative will depend on the successful roll-out of electronic prescription which the Federal Government has committed an additional $5 million of funding to fast track software capability,” he said.

 

“PSA has been working with the Government to build capability for electronic prescriptions for many years. Fast-tracking of e-prescriptions is appropriate to ensure people in isolation are able to receive their essential and regular medicines to maintain their health.

 

PSA supports the approach in fast tracking electronic prescriptions but more needs to be done to support community pharmacy in the adoption and implementation of this initiative.

 

“This is particularly significant as we know that people with other health conditions, such as cardiovascular disease, are at higher risk of complications of COVID-19.”

 

Associate Professor Freeman welcomed the funding of home delivery services as a pragmatic measure to ensure those people unable to leave their homes were not out of pocket at a time they were more likely to be under increased financial stress

 

“PSA has been working closely with the Federal Government to highlight issues pharmacists on the frontline are experiencing in supporting their patients, including security of medicine supply, the availability of Personal Protective Equipment (PPE), stockpiling of medicines and the continuation of emergency dispensing provisions,” he said.

 

“We will continue to work with the Government and the Health Minister, Greg Hunt, to ensure the roll-out of these initiatives is practical, effective and well-communicated to the pharmacist workforce.

 

“PSA will continue to inform the profession the details of these initiatives as they are worked through with the Department of Health.

 

“Australians look to their pharmacists for their healthcare advice and as frontline health providers it is important that pharmacists are supported by Government so they can continue to provide care for their patients.”

 

Media contact: PSA media 0487 922 176

 

Download media release

Leading NSW pharmacists honoured

Friday, 6 March 2020

 

Forbes based pharmacist Sarah Hazell has received the NSW pharmacist of the year award at the Annual Celebration of Excellence in Pharmacy, hosted by the Pharmaceutical Society of Australia (PSA).

 

PSA NSW Branch President Professor Peter Carroll presented the award to Ms Hazell at the Crown Plaza in Terrigal on Friday night.

 

Jennifer Culverson won the NSW Early Career Pharmacist of the year award and Michael Flannery was presented with the NSW Lifetime Achievement honour.

 

Professor Carroll congratulated Ms Hazell for her continued commitment in providing positive health outcomes to the local community.

 

“Sarah has a great understanding of the Forbes local community and has shown a real focus on developing not just pharmacists’ career progressions but also pharmacy assistants, nurses and dispensary technicians,” said Professor Carroll.

 

“Among many of her achievements, Sarah has enhanced indigenous health by initiating a QUMAX agreement with local medical centres, also developing a health hub with health professionals utilising clinic rooms such as Podiatrists, a Registered Nurse, an Audiometrist and Physiotherapists.

 

“Sarah is a leader in her community and a mentor to young pharmacists and is a well-deserved winner of this award.”

 

Jennifer Culverson from Orange was also recognised for her achievements, receiving the NSW Early Career Pharmacist of the Year award.

 

“Not only is Jennifer heavily involved in the education of pharmacy students at Charles Sturt University, she has also played a key role within the respiratory space on the medical ward at Orange Health Service over the past twelve months,” Professor Carroll said.

 

“Jennifer has the upmost respect from her colleagues and has shown outstanding commitment to expand the pharmacists’ role within the hospital setting through research and innovation.

 

“Over a period of time, Jennifer has demonstrated admirable qualities and displayed a high level of drive, determination and passion to extend the role of a pharmacist in the rapidly changing field of healthcare.”

 

Jennifer was also the recipient of the PSA/Bayer ECP grant valued at $8,500, which supports early career pharmacists in attending the main conference program at PSA’s Offshore Conference in Edinburgh and Belfast in 2020.

 

Professor Carroll also congratulated Sydney based pharmacist Michael Flannery who was presented with the NSW Lifetime Achievement award.

 

“Michael is the perfect example of the community pharmacist and has shown terrific passion and dedication to the pharmacy profession over many years.

 

“Managing Director and founder of Instigo, Micahel is also the founder of Pharmacy Catalyst and CEO of Life Pharmacy Group that has numerous examples of partners who Michael has mentored and supported from school student, through cadetship, to intern to Pharmacist and through to owner.

 

“Michael has also represented the pharmacy industry nationally and internationally as well as sitting on a number of committees and working groups.”

 

PSA Contact: Simone Diamandis: 0414 574 754

Government decision will protect more SA children from influenza

Friday, 6 March 2020

 

South Australian children will have increased access to life saving vaccinations thanks to changes in pharmacists’ scope of practice announced today by the Minister for Health and Wellbeing, Stephen Wade.

 

“Last year we saw South Australia hit by one of the worst flu seasons on record and the best way to protect our community in the future is through immunisation,” Pharmaceutical Society of Australia (PSA) South Australian President, Robyn Johns said.

 

“The more barriers we can remove to people getting vaccinated the better. The goal is herd immunity, having as many members of our community protected from infectious diseases like the flu as possible.

 

“Research shows consumers find pharmacies highly accessible because there is usually one in our neighbourhood or nearby and they are generally open longer hours than other primary health care services.

 

“Pharmacists already provide a range of vaccinations including flu vaccinations for South Australians 16 years and over. Now, pharmacists can extend this proven, safe service to children 10 years of age and above.”

 

“The Government is to be commended for bringing South Australia into line with pharmacist vaccination in Western Australia, Queensland, New South Wales and Tasmania, leading the way for other jurisdictions.”

 

Pharmacists authorised to provide vaccination services are trained in the administration of medicines. Pharmacists’ training to administer vaccines is similar to that completed by other health care professionals. The administration of vaccines by pharmacists complements the excellent work done by GPs, nurses, indigenous health workers and other immunisers.

 

“We believe this decision will protect more South Australians from influenza by increasing immunisation rates within our community at a time when people are concerned about protecting themselves from the communicable diseases,” Ms Johns said.

 

“We need people to be protected from all vaccine-preventable diseases, particularly at this time when there are concerns about the impact of coronavirus in our community.”

 

PSA continues to advocate for a national approach to pharmacist administered vaccinations to reduce confusion, ensure better access for patients to quality vaccination services and utilise the pharmacist workforce appropriately.

 

Media contact: Helen Stone, 0418 846 426

Pharmacists to boost influenza vaccination rates for children in NSW

Pharmacists in New South Wales will be able to administer the influenza vaccination to children aged 10 and above, in a move announced by the NSW Government that has been welcomed by the Pharmaceutical Society of Australia (PSA).

 

PSA NSW Branch President, Professor Peter Carroll, congratulated NSW Health Minister Brad Hazzard on today’s announcement to enable pharmacists to better protect the community from influenza from mid-March.

 

“This is a significant announcement from the NSW Government and will protect younger children from influenza and significantly increase immunisation rates in the state,” he said.

 

“During 2019, NSW recorded the highest confirmed cases of influenza in Australia with children particularly susceptible to the flu. Studies have found that less than a third of children are being immunised each flu season and influenza causes a substantial number of ICU admissions in Australian children each year.”

 

Professor Carroll said NSW children would now be better protected from influenza as today’s announcement would allow families greater access to the vaccine and was particularly timely with the upcoming flu season.

 

“Allowing pharmacists to vaccinate makes it more convenient for families, providing greater access to the influenza vaccine and improving rates of immunisation,” he said.

 

“Already, this year there has been 4,725 confirmed cases of influenza in NSW and with the likely convergence of a COVID-19 pandemic with winter influenza, this move will help to bolster immunity in NSW.

 

“Boosting vaccination rates and preventing influenza outbreaks can ease pressure on our GP surgeries and hospital emergency departments.

 

Professor Carroll said as the peak national body for pharmacists, PSA has previously advocated, including most recently in PSA’s NSW pre-budget submission, to allow pharmacists to improve access to influenza vaccinations for adolescents.

 

“PSA commends the NSW Government and NSW Health for continuing to progress recommendations made to better protect the community,” he said.

 

Media contact: PSA NSW State Manager, Simone Diamandis – (02) 9431 1100

Leading SA and NT pharmacists honoured

Respected Northern Territory pharmacist Shelley Forester has received the SA/NT Pharmacist of the Year Award at the Annual Celebration of Excellence in Pharmacy hosted by the Pharmaceutical Society of Australia (PSA).

 

SA Minister for Health and Wellbeing, the Hon Stephen Wade MLC presented the award to Ms Forester at the Adelaide Pavilion on Friday night.

 

Dr Renly Lim from South Australia won the SA/NT Early Career Pharmacist Development Award and Raymond Truong was presented with the 2019 PSA Gold Medal.

 

PSA SA/NT President Robyn Johns congratulated Ms Forester and commended her significant contribution in the establishment and operation of the Maningrida Pharmacy service with Mala’la Health Service in 2014.

 

“This service was a pioneer of how a community pharmacy and an ACCHO can collaborate to improve the access to a pharmacist for remote Aboriginal and Torres Strait Islander people,” said Ms Johns.

 

“Shelley has been a longtime supporter of the NT Pharmacy Program and is a critical supporter of local PSA initiatives including the Early Career Pharmacist and My Health Record.”

 

“Not only is Shelley a terrific mentor for early career pharmacists but she has also shown a commitment in hiring NT interns and is a worthy recipient for the SA/NT Pharmacist of the Year award in recognition of her tireless dedication to NT Pharmacy.”

 

President elect of the Young Pharmacists’ Group FIP Dr Renly Lim received the SA/NT Early Career Pharmacist Development Award.

 

“Dr Lim is an outstanding early career research pharmacist who is significantly contributing to the development of the pharmacy profession nationally and internationally,” said Ms Johns.

 

“Not only is Dr Lim an existing leader for young pharmacists internationally, she was also lead author of PSA’s Medicine Safety report, providing the evidence which led to quality use of medicines and medicine safety becoming Australia’s 10th national health priority.”

 

Ms Johns also congratulated PSA Gold Medal winner Raymond Truong, who completed the Bachelor of Pharmacy degree at the University of South Australia in 2019.

 

“Raymond is entering his intern year and is a well-deserved winner of the 2019 PSA Gold Medal Award.”

 

Media contact: Helen Stone 0418846426

 

Download media release

Increased Home Medicine Review caps from March 2020 will help reduce the harm caused by medicines

Friday, 28 February 2020

 

Australia’s elderly will be better supported to avoid medicine-related harm under a relaxing of caps restricting access to Home Medicine Reviews (HMRs) announced today.

 

In changes announced today, accredited pharmacists will be able to provide up to 30 HMRs per month from 1 March 2020, an increase of the current 20 HMRs per month cap which has existed since February 2014.

 

“PSA welcomes this change which will help increase consumer access to HMRs across the country,” National President, Associate Professor Chris Freeman said. “PSA have been calling for better access to medicine reviews for some time, most recently through recommendations contained in our Medicine Safety: Aged care report released earlier this week.”

 

“Medicine-related problems lead to 250,000 hospital admissions each year costing $1.4 billion annually. Medicine review services undertaken by accredited pharmacists, such as HMRs, are a key way in which problems with medicines are identified and resolved in partnership with consumers and their general practitioner.”

 

Home Medicine Reviews not only can improve a patient’s quality of life, but can save lives. We know that patients who take more than one medicine can be at risk of major problems associated with their medicines. Home Medication Reviews can improve the outcomes from medicine use in Australia, said Associate Professor Freeman.

 

“Our members have told us of significant delays consumers have experienced waiting for the calendar to tick over to the next month before being able to receive a HMR from their pharmacist who has hit their HMR cap for the month”, Associate Professor Freeman said. “Australians living in rural and remote parts of the country are one of the main groups to struggle with health care accessibility. The cap of 20 HMRs per month particularly hits hard on consumers living in rural communities where there is usually no other accredited pharmacists available to provide the service.”

 

“PSA has called for the removal of these caps since their inception. We would like to thank the Minister for Health for this announcement today on behalf of all pharmacists and their patients. We are pleased with today’s announcement as a first step and we are committed to continue working with Government to further improve access to medicine review services.”

 

Media contact: PSA Media – 0487 922 176